The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to ...

The global motion stimulation therapy market is set for significant growth, with market projections estimating its value at USD 1.4 billion in 2024. Fueled by rapid technological integration in ...

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...

NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

What is the immune system? The immune system works to keep germs and other foreign substances out of the body and destroy any that get in. It's made up of a complicated network of cells and organs. It ...

The company has a pipeline of technologies, including its implantable ARC-IM SCS system. It also has an investigational platform that uses a brain-computer interface (BCI) powered by AI.

“There’s nowhere in our system of justice, in our society, in the state of South Carolina, that’s more in crisis than our family courts,” Kittredge said. Cases are rising, and there are ...

CEO Scavilla emphasized the launch of 18 new products in 2024, including the QUARTEX MIS system, ALLEGIANCE Retractor ... Scavilla announced the acquisition of Nevro Corporation for $250 million ...